400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / CCR / GW 766994
CAS No.: 408303-43-5
Synonyms: GW 994
GW 766994 is a specific and oral chemokine receptor-3 (CCR3) antagonist, which has entered clinical trial for asthma and eosinophilic bronchitis.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01160224 | Asthma | Phase 2 | Completed | - | Canada, Alberta ... more >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 Collapse << |
实验方案
技术信息
CAS号 | 408303-43-5 | 储存条件 |
|
|
分子式 | C21H24Cl2N4O3 | 运输 | 蓝冰 | |
分子量 | 451.35 | 别名 | GW 994 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01160224 | Asthma | Phase 2 | Completed | - | Canada, Alberta ... more >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网